Robinhood Markets, Inc.’s Silexion Therapeutics SLXN Stock Holding History
Bought
Maintained
Sold
Other funds holding SLXN
WAM
BP
PK
Robinhood Markets, Inc.'s SLXN Position: Q3 2026 in Review
Robinhood Markets, Inc. opened a new position in Silexion Therapeutics (SLXN) in Q3 2026: 6 shares worth $40. The stake represents ﹤0.01% of the portfolio and ranks #1264 among its holdings.
10 funds tracked by Wall St. Rank hold SLXN as of Q3 2026.
- Robinhood Markets, Inc. held 6 shares of Silexion Therapeutics worth $40 as of Q3 2026.
- Silexion Therapeutics was a new Robinhood Markets, Inc. position in Q3 2026.
- Silexion Therapeutics made up ﹤0.01% of Robinhood Markets, Inc.'s portfolio in Q3 2026, its #1264 holding.
- 10 funds tracked by Wall St. Rank held Silexion Therapeutics as of Q3 2026.
Based on Robinhood Markets, Inc.'s 13F filing for Q3 2026, filed 18 Nov 2026.